Foxglove Pharma · Annual license

Foxglove Pharma · D-1011

Deal value

$89,000

Probability

10%

Expected close

Jan 15, 2027

Owner

Tomas Berg

Stage

Activity

Call: Discovery call with Maya
Covered goals, timeline and current tooling.
Tomas Berg · Nov 1, 2026 (yesterday)
Email: Sent overview to Maya
Shared the product deck and two customer stories.
Tomas Berg · Oct 22, 2026 (11 days ago)
Meeting: Demo for Maya's team
Walked through the workflow end to end.
Tomas Berg · Oct 12, 2026 (21 days ago)
Call: Pricing call with Maya
Talked through seats, term and onboarding.
Tomas Berg · Oct 1, 2026 (32 days ago)
Email: Follow-up to Maya
Answered security and procurement questions.
Tomas Berg · Sep 21, 2026 (42 days ago)
Note: Deal created
Source: Outbound. Added to the Lead stage.
Tomas Berg · Sep 11, 2026 (sep 11)

Notes

Main concern is migration effort. Offered a guided onboarding.
Tomas Berg · Sep 23, 2026
Champion is the head of operations. Needs a business case for finance.
Tomas Berg · Sep 14, 2026

Contacts on this deal

Tasks

Details